Clinical

Patrick Campbell is the senior editor of Endocrinology Network, as well as its sister publication Practical Cardiology. Prior to joining these brands, he led coverage of cardiology and diabetes with HCPLive. Before joining parent company MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a freelance multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. In his free time, he enjoys traveling, sports, and exploring the great outdoors. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

Articles

Data from LINC3 and LINC4 provide insight into the impact of dosing titration schedules on risk of hypocortisolism-related adverse events associated with osilodrostat use in patients with Cushing's disease.

More Gradual Dose Titration Could Reduce Hypocortisolism Risk with Osilodrostat in Cushing's Disease

Podcasts

Georgiana Dobri, MD, a neuroendocrinologist from Weill Cornell Medicine, discusses the approval of osilodrostat and management of Cushing's disease in 2020.

 Osilodrostat and Treatment of Cushing's Disease

Study of levoketoconazole for Cushing’s syndrome shows significant improvements in acne, hirsutism in women, and peripheral edema.

Phase Three Study Demonstrates Promising New Treatment for Cushing’s Syndrome

® Cushing’s Disease clinical resource center is a hub for the latest in the management and diagnosis of Cushing’s disease. Often referred to as hypercortisolism, this page will host content including articles, videos, podcasts, and clinician-authored columns.